Quick charity verification for Cure Duchenne (EIN: 200299958)
Verdict: Cure Duchenne appears trustworthy
90/100Mission Score
$14.0MRevenue
$30.9MAssets
1Red Flags
4Strengths
Red Flags
Expenses consistently exceeding revenue in recent years (2021-2023), potentially impacting long-term sustainability if not addressed.
Strengths
Consistent reporting of 0% officer compensation, indicating high transparency and mission focus.
Significant growth in assets over the past decade, demonstrating financial stability and capacity.
Clear alignment between NTEE code (H50) and organizational mission.
Strong historical revenue generation, including a peak of over $27 million in 2019.
Spending Breakdown
How Cure Duchenne allocates its funds across programs, administration, and fundraising.
85%
Program Spending
Healthy — majority goes to mission
10%
Admin Costs
Reasonable — admin costs in check
5%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.
How to Interpret This Report
What Red Flags Mean
Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.
What Mission Score Measures
The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.
Using This Data for Donation Decisions
Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.
Frequently Asked Questions about Cure Duchenne
Is Cure Duchenne a legitimate charity?
Based on AI analysis of IRS 990 filings, Cure Duchenne (EIN: 200299958) appears trustworthy. Mission Score: 90/100. 1 red flag identified, 4 strengths noted.
Is Cure Duchenne a good charity to donate to?
Cure Duchenne has a Mission Score of 90/100. Revenue: $14.0M. Assets: $30.9M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.
What is the EIN for Cure Duchenne?
The Employer Identification Number (EIN) for Cure Duchenne is 200299958. This is the unique tax ID assigned by the IRS.
What is a Mission Score?
The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.
How does Cure Duchenne spend its money?
Cure Duchenne allocates 85% to programs, 10% to administration, and 5% to fundraising. Healthy nonprofits typically spend 75%+ on programs.
How can I verify Cure Duchenne's tax-exempt status?
You can verify Cure Duchenne's tax-exempt status using EIN 200299958 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.
AI Transparency Report
Cure Duchenne demonstrates a strong commitment to its mission, as evidenced by its consistent program spending. While the organization has experienced fluctuations in revenue, notably a significant spike in 2019 to over $27 million, its expenses have shown a steady increase, indicating growing operational capacity. The organization's assets have also grown substantially over the years, from $6.7 million in 2018 to over $27 million in 2023, suggesting sound financial management and accumulation of resources to support its long-term goals. The consistent reporting of 0% officer compensation across all available filings is a significant indicator of transparency and a focus on directing funds towards the mission rather than executive salaries.
However, recent filings show expenses exceeding revenue, with 2023 revenue at $7,357,938 against expenses of $10,247,154, and similar trends in 2022 and 2021. This trend, if sustained, could impact long-term financial stability, although current asset levels appear robust enough to absorb these short-term deficits. The organization's NTEE code H50 (Diseases, Disorders, Medical Disciplines) aligns well with its name, Cure Duchenne, indicating a clear programmatic focus. Overall, Cure Duchenne appears to be a financially healthy organization with a strong mission focus and excellent transparency regarding executive compensation.